Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Biomarkers, Tumor | 3 | 2019 | 1314 | 1.15 | Why? |
| Precision Medicine | 4 | 2021 | 1477 | 0.88 | Why? |
| Mitochondrial Diseases | 1 | 2021 | 62 | 0.84 | Why? |
| Triple Negative Breast Neoplasms | 1 | 2017 | 92 | 0.65 | Why? |
| Energy Metabolism | 1 | 2021 | 451 | 0.63 | Why? |
| MicroRNAs | 2 | 2019 | 1787 | 0.60 | Why? |
| Mammography | 1 | 2019 | 410 | 0.58 | Why? |
| Preventive Medicine | 1 | 2018 | 242 | 0.55 | Why? |
| Glaucoma | 1 | 2018 | 225 | 0.53 | Why? |
| Mitochondria | 1 | 2021 | 857 | 0.52 | Why? |
| Breast Neoplasms | 4 | 2019 | 3633 | 0.52 | Why? |
| Picolinic Acids | 1 | 2012 | 6 | 0.52 | Why? |
| Wound Healing | 1 | 2017 | 424 | 0.50 | Why? |
| Neoplasm Proteins | 1 | 2017 | 501 | 0.48 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1014 | 0.46 | Why? |
| Diabetes Mellitus, Experimental | 1 | 2012 | 192 | 0.42 | Why? |
| Oxidative Stress | 1 | 2021 | 2050 | 0.40 | Why? |
| Genomics | 1 | 2019 | 3118 | 0.33 | Why? |
| Proteomics | 3 | 2018 | 2481 | 0.24 | Why? |
| Transcription Factor AP-2 | 1 | 2018 | 9 | 0.19 | Why? |
| Anticarcinogenic Agents | 1 | 2018 | 25 | 0.19 | Why? |
| Low Tension Glaucoma | 1 | 2018 | 4 | 0.19 | Why? |
| Carcinogenesis | 1 | 2021 | 236 | 0.19 | Why? |
| Electrophoresis, Gel, Two-Dimensional | 1 | 2017 | 40 | 0.18 | Why? |
| DNA Repair | 1 | 2018 | 114 | 0.17 | Why? |
| Neoplasm Metastasis | 2 | 2018 | 682 | 0.17 | Why? |
| Epigenomics | 1 | 2018 | 139 | 0.17 | Why? |
| Drug Resistance, Multiple | 1 | 2018 | 156 | 0.16 | Why? |
| Matrix Metalloproteinase 9 | 1 | 2018 | 211 | 0.16 | Why? |
| Vasoconstriction | 1 | 2018 | 153 | 0.16 | Why? |
| Reactive Oxygen Species | 1 | 2021 | 1136 | 0.14 | Why? |
| Neurodegenerative Diseases | 1 | 2021 | 469 | 0.14 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2017 | 449 | 0.13 | Why? |
| DNA Breaks | 1 | 2012 | 1 | 0.13 | Why? |
| Comet Assay | 1 | 2012 | 6 | 0.13 | Why? |
| Superoxide Dismutase-1 | 1 | 2012 | 21 | 0.13 | Why? |
| RNA, Long Noncoding | 1 | 2018 | 408 | 0.12 | Why? |
| Metabolomics | 1 | 2018 | 921 | 0.12 | Why? |
| Superoxide Dismutase | 1 | 2012 | 155 | 0.12 | Why? |
| Transcription, Genetic | 1 | 2018 | 1326 | 0.11 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2012 | 6166 | 0.11 | Why? |
| Phytochemicals | 1 | 2018 | 678 | 0.11 | Why? |
| Apoptosis | 2 | 2018 | 2335 | 0.11 | Why? |
| DNA Damage | 1 | 2012 | 285 | 0.10 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2012 | 310 | 0.10 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.09 | Why? |
| Practice Guidelines as Topic | 1 | 2012 | 15421 | 0.09 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.08 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.08 | Why? |
| Dose-Response Relationship, Drug | 1 | 2012 | 3776 | 0.06 | Why? |
| Gene Expression Regulation | 1 | 2012 | 4020 | 0.05 | Why? |
| Animals | 3 | 2021 | 78931 | 0.05 | Why? |
| Sulfur Compounds | 1 | 2018 | 17 | 0.05 | Why? |
| Carotenoids | 1 | 2018 | 70 | 0.05 | Why? |
| Mass Screening | 1 | 2018 | 8005 | 0.04 | Why? |
| Cell Hypoxia | 1 | 2018 | 141 | 0.04 | Why? |
| Neoplastic Stem Cells | 1 | 2018 | 120 | 0.04 | Why? |
| RNA, Untranslated | 1 | 2018 | 140 | 0.04 | Why? |
| Humans | 8 | 2021 | 930598 | 0.04 | Why? |
| Phenols | 1 | 2018 | 226 | 0.04 | Why? |
| Neovascularization, Pathologic | 1 | 2018 | 305 | 0.03 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.03 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.03 | Why? |
| Female | 4 | 2019 | 380317 | 0.03 | Why? |
| Mice | 1 | 2012 | 21357 | 0.03 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.03 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2018 | 2654 | 0.02 | Why? |
| Treatment Outcome | 1 | 2012 | 51732 | 0.02 | Why? |
| Adult | 1 | 2017 | 244371 | 0.01 | Why? |
| Middle Aged | 1 | 2017 | 270681 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.01 | Why? |
Golubnitschaja's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(72)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(68)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_